Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Acta Neurol Scand ; 117(1): 35-40, 2008 Jan.
Article de Anglais | MEDLINE | ID: mdl-18095953

RÉSUMÉ

OBJECTIVE: To assess hallucinations in Parkinson's disease (PD), we developed a novel practical rating scale that evaluates five items including variety, frequency, and severity of hallucinations, caregiver burden levels, and psychiatric status at nighttime. METHODS: Forty-one PD patients and their caregivers were examined regarding the status of the hallucinations associated with PD. RESULTS: As a measure of internal consistency, the Tottori University Hallucination Rating Scale (TUHARS) has a Cronbach's alpha of 0.88. Mini-Mental State Examination (MMSE) and Hoehn-Yahr stage were associated with the TUHARS scores in a multivariate regression analysis. Visual hallucinations are the most common. However, half of the patients who reported visual hallucinations also had other hallucinations. The scale scores in the PD patients with dementia (PDD) group were significantly greater than in the PD patients without dementia (PDnD) group. CONCLUSIONS: TUHARS appears to be a suitable and easily administered instrument for assessment of hallucinations in PD. PD patients experienced various kinds of hallucinations. Hallucinations may have a close relationship with cognitive decline in PD patients.


Sujet(s)
Évaluation de l'invalidité , Hallucinations/diagnostic , Hallucinations/étiologie , Tests neuropsychologiques , Maladie de Parkinson/complications , Sujet âgé , Démence/complications , Démence/physiopathologie , Démence/psychologie , Femelle , Hallucinations/physiopathologie , Humains , Mâle , Maladie de Parkinson/physiopathologie , Maladie de Parkinson/psychologie , Valeur prédictive des tests , Sensibilité et spécificité , Indice de gravité de la maladie
2.
J Neural Transm (Vienna) ; 114(12): 1579-83, 2007.
Article de Anglais | MEDLINE | ID: mdl-17690946

RÉSUMÉ

Dementia with Lewy bodies (DLB) is the second most common senile degenerative dementia after Alzheimer's disease (AD). The presentation of overlapping symptoms between these two disorders leads to difficulties in the determination of clinical entities. Serum samples were subjected to surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) analysis in order to identify a diagnostic marker for DLB. Four putative protein peaks (m/z 3,883, 4,964, 7,761 and 10,534) were differentially expressed in DLB patients compared to AD patients and control subjects. Receiver operating characteristics (ROC) analysis of a multivariate logistic model of the combination of three peaks (m/z 3,883, 7,761 and 10,534) exhibited the highest discriminatory ability of DLB subjects from non-DLB subjects with a sensitivity of 83.3%, a specificity of 95.8%, a positive predictive value of 90.9% and a negative predictive value of 92.0%. SELDI-TOF MS profiling, therefore, has revealed a serum signature with high diagnostic potential for DLB.


Sujet(s)
Marqueurs biologiques/sang , Maladie à corps de Lewy/sang , Maladie à corps de Lewy/diagnostic , Protéomique/méthodes , Spectrométrie de masse MALDI , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Analyse par réseau de protéines , Courbe ROC , Sensibilité et spécificité
3.
Acta Neurol Scand ; 116(3): 190-5, 2007 Sep.
Article de Anglais | MEDLINE | ID: mdl-17714333

RÉSUMÉ

OBJECTIVES: In order to explore factors associated with the development of dementia in Parkinson's disease (PD) and Dementia with Lewy bodies (DLB), we systematically investigated the clinical evaluation of PD and DLB patients hospitalized in the Department of Neurology at Tottori University Hospital, Japan. RESULTS: There were 208 patients diagnosed as having PD and 39 patients diagnosed with DLB in this study. Of the patients with PD, 67 (32%) developed dementia and only five PD+ patients were considered to have cognitive impairment attributable to Alzheimer's disease (AD) or vascular dementia (VaD). Fifty-four (81%) PDD patients had visual hallucinations (VH) with or without cognitive fluctuation. The onset age of parkinsonian motor symptoms of patients with PD dementia (PDD) did not differ from that of PD patients without dementia. There was a significant inverse correlation between the onset age of motor symptoms in PD and the onset of their dementia in PDD. Seventy-five (36%) patients with PD had experienced VH and most of the PDD patients had experienced VH within 1 year before or after diagnosis of PDD. CONCLUSIONS: These results indicate that aging and VH are important factors associated with dementia in PD.


Sujet(s)
Vieillissement/psychologie , Troubles de la cognition/étiologie , Démence/étiologie , Hallucinations/étiologie , Maladie à corps de Lewy/psychologie , Maladie de Parkinson/psychologie , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Hospitalisation , Humains , Japon , Mâle , Adulte d'âge moyen , Facteurs de risque
4.
Int J Oral Maxillofac Surg ; 34(8): 915-20, 2005 Dec.
Article de Anglais | MEDLINE | ID: mdl-15955662

RÉSUMÉ

Peroxiredoxin (Prx) I is an antioxidant protein expressed in proliferating cells. We investigated Prx I as marker for tongue cancer status by correlating clinical features with Prx I expression. Samples from 132 patients with squamous cell carcinoma in the tongue were examined by immunohistochemistry with an anti-Prx I antibody. Correlations between Prx I expression and the clinical features of tumors were statistically determined using univariate and multivariate analyses. Univariate analysis showed Prx I was significantly associated with local recurrence (P=0.033). By multiple logistic regression analysis, Prx I expression was associated with local recurrence (odds ratio: 2.84; 95% confidence interval: 1.09-7.43; P=0.034) and lymph node recurrence (odds ratio: 2.86; 95% confidence interval: 1.02-8.01; P=0.046). Our results suggested that Prx I expression indicates tumors with a high potential for recurrence. Prx I may be used clinically to guide treatment for squamous cell carcinoma of the tongue.


Sujet(s)
Carcinome épidermoïde/enzymologie , Récidive tumorale locale/enzymologie , Peroxirédoxines/biosynthèse , Tumeurs de la langue/enzymologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Analyse de variance , Marqueurs biologiques tumoraux , Carcinome épidermoïde/génétique , Carcinome épidermoïde/anatomopathologie , Femelle , Expression des gènes , Humains , Techniques immunoenzymatiques , Modèles logistiques , Métastase lymphatique , Mâle , Adulte d'âge moyen , Stadification tumorale , Tumeurs de la langue/génétique , Tumeurs de la langue/anatomopathologie
6.
Neurosci Lett ; 293(1): 49-52, 2000 Oct 20.
Article de Anglais | MEDLINE | ID: mdl-11065135

RÉSUMÉ

Heme[none1] oxygenase-1 (HO-1) and peroxiredoxin I (PrxI) are known to be oxidative stress- and heme-related proteins. The antioxidant activity of PrxI is inhibited by heme, therefore co-expression of HO-1 and PrxI is considered to be a reasonable mechanism to maintain its antioxidative function. Immunoblotting demonstrated that HO-1 and PrxI were induced around the hemorrhagic region. Immunohistochemical studies revealed that, in acute phase, HO-1 and PrxI were induced primarily in microglia. In the subacute and chronic phase, the immunoreactivity of HO-1 and PrxI in astrocytes was the most intense. These data are the first to demonstrate co-induction of HO-1 and PrxI in the brain. Our results suggest that HO-1 and PrxI are localized in a similar manner to assure the antioxidant activity of PrxI under stress conditions associated with intracerebral hemorrhage.


Sujet(s)
Astrocytes/métabolisme , Encéphale/métabolisme , Hémorragie cérébrale/métabolisme , Heme oxygenase (decyclizing)/métabolisme , Microglie/métabolisme , Peroxidases/métabolisme , Animaux , Encéphale/anatomopathologie , Induction enzymatique , Heme oxygenase-1 , Immunotransfert , Immunohistochimie , Mâle , Peroxirédoxines , Rats , Rat Wistar
7.
Rinsho Shinkeigaku ; 40(6): 617-20, 2000 Jun.
Article de Japonais | MEDLINE | ID: mdl-11086405

RÉSUMÉ

A 55-year-old man, who had been medicated with carbamazepine, phenobarbital, and sodium valproate for 12 years' duration, presented with severe headache, nausea, and transient diplopia. The neurological examination revealed mild disturbance of consciousness and postural tremor. He also complained of severe continuous headache but no throbbing pain. Enhanced head CT showed empty delta sign and irregular pooling of contrast agent around the superior sagittal sinus. Head MRI did not show the flow void in the superior sagittal sinus. Cerebral angiography demonstrated incomplete occlusion of the superior sagittal sinus and well-developed colateral channels. He was diagnosed having superior sagittal sinus thrombosis, and was placed on anticoagulant and antiplatelet drugs. He did not have any other risk factors such as inflammatory disease, infection, malignancy, and oral contraceptives. However, he had been medicated with some anticonvulsants including carbamazepine, which is known to induce venous thrombosis in the leg. Therefore, the association between superior sagittal sinus thrombosis and long term medication with carbamazepine was suspected. This is the first case report of anticonvulsant-associated cerebral venous thrombosis. It suggests that long-term medication with carbamazepine should be considered to be one of the risk factors for cerebral venous thrombosis.


Sujet(s)
Anticonvulsivants/effets indésirables , Carbamazépine/effets indésirables , Thrombose du sinus sagittal/induit chimiquement , Anticonvulsivants/administration et posologie , Carbamazépine/administration et posologie , Humains , Soins de longue durée , Mâle , Adulte d'âge moyen
8.
Brain Res Mol Brain Res ; 81(1-2): 92-100, 2000 Sep 30.
Article de Anglais | MEDLINE | ID: mdl-11000481

RÉSUMÉ

Most synapses contain high concentrations of neurotransmitter receptors in the postsynaptic plasma membrane. Agrin (Ag) is an extracellular matrix protein necessary for the localization of acetylcholine receptors at the neuromuscular junction and for the differentiation of synapses in hippocampal neurons in vitro. The temporal pattern of agrin expression during the development of the central nervous system (CNS) is consistent with the notion that agrin expression is regulated during synaptogenesis. To identify the processes underlying this regulation, we have analyzed levels and alternative splicing of agrin mRNA in primary hippocampal neurons. Our results indicate that in the initial phases of synapse formation, contact-mediated processes and action potential-dependent neurotransmission regulate agrin mRNA expression, while secreted factors from glial cells, but not from hippocampal neurons, influence the alternative splicing of agrin mRNA. Previous studies have shown that specific agrin isoforms are able to induce the activation of a transcription factor and that secreted agrin associates with cellular surfaces. Therefore, we have tested whether agrin isoforms contribute to the contact-mediated induction of agrin expression in hippocampal neurons. None of the agrin isoforms tested in this study revealed this activity. Finally, we show that the role of evoked neural transmission in controlling agrin transcription changes during differentiation in vitro.


Sujet(s)
Potentiels d'action/physiologie , Agrine/génétique , Épissage alternatif , Communication cellulaire/physiologie , Régulation de l'expression des gènes/physiologie , Hippocampe/physiologie , Neurones/physiologie , Synapses/physiologie , Animaux , Cellules cultivées , Embryon de mammifère , Hippocampe/cytologie , Cinétique , Souris , Souris de lignée C57BL , Neurones/cytologie , ARN messager/génétique , Rats , Rat Sprague-Dawley , Facteurs temps
9.
Neurology ; 55(3): 437-40, 2000 Aug 08.
Article de Anglais | MEDLINE | ID: mdl-10932284

RÉSUMÉ

Plasma homocysteine and cysteine levels were measured in 90 patients with PD with the MTHFR C677T (T/T) genotype. The authors found that the levels of homocysteine-a possible risk factor for vascular disease-were elevated by 60% in levodopa-treated patients with PD, with the most marked elevation occurring in patients with the T/T genotype. Cysteine levels in subjects with PD did not differ from levels in control subjects. In the T/T genotype patients, homocysteine and folate levels were inversely correlated. Increased homocysteine might be related to levodopa, MTHFR genotype, and folate in PD.


Sujet(s)
Homocystéine/sang , Oxidoreductases acting on CH-NH group donors/génétique , Maladie de Parkinson/sang , Maladie de Parkinson/génétique , Mutation ponctuelle , Sujet âgé , Sujet âgé de 80 ans ou plus , Antiparkinsoniens/administration et posologie , Cystéine/sang , Femelle , Acide folique/sang , Génotype , Humains , Lévodopa/administration et posologie , Mâle , Methylenetetrahydrofolate reductase (NADPH2) , Adulte d'âge moyen , Maladie de Parkinson/traitement médicamenteux
10.
Neurosci Lett ; 282(1-2): 57-60, 2000 Mar 17.
Article de Anglais | MEDLINE | ID: mdl-10713395

RÉSUMÉ

A170 and heme oxygenase-1 (HO-1) are characterized as oxidative stress-inducible proteins whose induction depends upon common transcription factor via antioxidant responsive element. We investigated the expression of A170 and HO-1 in the cerebellum after kainate administration. In situ hybridization showed constitutive expression of A170 and HO-1 mRNA in Purkinje cell layer; mild induction of A170 or HO-1 was detected, respectively, 8 or 24 h after kainate administration. Immunohistochemical studies also demonstrated that constitutive expression and the induction of A170 protein in Purkinje cells; the induction of HO-1 protein was detected in Bergmann glia but not in Purkinje cells. Thus, the transcription factors involved in the induction of A170 might be different from those in the induction of HO-1 under kainate-mediated excitotoxicity. The existence of cell type-specific stress response was suggested.


Sujet(s)
Cervelet/métabolisme , Protéines du choc thermique/biosynthèse , Heme oxygenase (decyclizing)/biosynthèse , Stress oxydatif , Animaux , Technique de Northern , Cervelet/enzymologie , Induction enzymatique , Agonistes des acides aminés excitateurs , Heme oxygenase-1 , Immunohistochimie , Hybridation in situ , Acide kaïnique , Mâle , Rats , Rat Wistar , Séquestosome-1
11.
Brain Res Mol Brain Res ; 69(2): 155-63, 1999 Jun 08.
Article de Anglais | MEDLINE | ID: mdl-10366737

RÉSUMÉ

Stress proteins play important roles in the protective mechanisms under critical conditions for cell survival. We report here the expression of A170 and MSP23, oxidative stress-inducible proteins, under kainate-mediated excitotoxicity in the rat brain. A170 mRNA was significantly induced in the brain 5-8 h after i.p. kainate administration. MSP23 mRNA was observed at quite a low level in the rat brain, and the induction of MSP23 mRNA was not observed during the period 24 h after kainate administration. Immunoblot analysis demonstrated that the maximal expression level of A170 protein occurred 8 h after treatment in each part of the brain. MSP23 protein was constitutively expressed in the brain and the level of this protein was significantly decreased during the period 24 h after kainate administration. In situ hybridization and immunohistochemical studies showed that A170 was expressed predominantly in neurons, especially in pyramidal neurons of the cerebrum and cerebellar Purkinje cells, while MSP23 was expressed in oligodendrocytes. The induction of A170 was observed in the regions which are affected by excitotoxicity and this induction was observed in the earlier phase than cell death. Also, the region which shows high vulnerability to excitotoxicity such as pyramidal cell layer in the hippocampus, showed lower A170 expression than that which shows resistance to excitotoxicity, such as the dentate gyrus in the hippocampus. These results suggest that A170 may play a protective role in the brain under kainate-mediated excitotoxicity.


Sujet(s)
Encéphale/effets des médicaments et des substances chimiques , Acide kaïnique/pharmacologie , Protéines de tissu nerveux/biosynthèse , Stress oxydatif/physiologie , Peroxidases , Animaux , Encéphale/métabolisme , Protéines du choc thermique/biosynthèse , Immunohistochimie , Hybridation in situ , Mâle , Peroxirédoxines , Rats , Rat Wistar , Séquestosome-1
12.
Biochem Biophys Res Commun ; 259(1): 91-6, 1999 May 27.
Article de Anglais | MEDLINE | ID: mdl-10334921

RÉSUMÉ

Heme oxygenase-1 (HO-1) is induced under various stresses. Here we report the induction and localization of HO-1 in the rat brain by intraperitoneal administration of kainic acid (KA). Both mRNA and protein of HO-1 were markedly induced by KA treatment, and each maximal induction was observed 24 h after KA administration. In situ hybridization analysis showed that HO-1 mRNA appeared predominantly in glial cells, and confined neurons were positive in the cerebral cortex, basal ganglia, and hippocampal pyramidal cell layer. Immunohistochemical analysis showed that the positive cells in the cerebral cortex and hippocampus were mainly astrocytes and microglia, whereas neurons in the basal ganglia showed intense immunoreactivity. We also demonstrate the dissociation between HO-1 mRNA and protein level in the hippocampal pyramidal neurons, which is known to be vulnerable against excitotoxicity, and discuss the correlation between this dissociation and the vulnerability of hippocampal pyramidal neurons.


Sujet(s)
Encéphale/enzymologie , Agonistes des acides aminés excitateurs/pharmacologie , Heme oxygenase (decyclizing)/biosynthèse , Acide kaïnique/pharmacologie , Protéines de tissu nerveux/métabolisme , ARN messager/métabolisme , Animaux , Encéphale/cytologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Heme oxygenase-1 , Immunohistochimie , Hybridation in situ , Mâle , Protéines de tissu nerveux/génétique , Rats , Rat Wistar , Facteurs temps
13.
Talanta ; 44(5): 765-70, 1997 May.
Article de Anglais | MEDLINE | ID: mdl-18966799

RÉSUMÉ

A spectrophotometric flow-injection method for determining copper(II) has been developed. It is based on the catalytic effect of copper(II) on the oxidative coupling of N-phenyl-p-phenylenediamine with m-phenylenediamine in the presence of hydrogen peroxide. Pyridine and ammonia as activators increased the absorbance for the copper(II)-catalyzed coloration, and the dye formed was stabilized by adding a non-ionic surfactant. The working range of the method was 0.1-2.0 ng ml(-1) of cooper(II) with a relative standard deviation 2.4% at a sampling rate of 30 h(-1). Interference from iron(III) was effectively suppressed by citric acid. Copper in natural water samples can be determined easily.

14.
Rinsho Shinkeigaku ; 36(5): 692-5, 1996 May.
Article de Japonais | MEDLINE | ID: mdl-8905992

RÉSUMÉ

We reported a 72-year-old man with left supranuclear hypoglossal nerve palsy and right Avellis' syndrome due to a medullary small infarction. On admission, he showed slight disturbance of consciousness, ocular lateropulsion to the right side, rotatory nystagmus, dysarthria, absent right gag reflex, curtain sign, absent right palatal reflex, deviation of the uvula toward the left side, raise of only the left palate when the patient attempted to utter, paralysis of the right vocal cord and deviation of the tongue toward the left side. Neither atrophy nor fasciculation was observed on the tongue. 124 days after the onset, he had only the left supranuclear hypoglossal nerve palsy and right Avellis' syndrome. MRI showed a small lesion in the medulla, so lateral area of the medulla and a part of the reticular formation medial to the nucleus ambiguous presumed to be involved. These findings suggest that supranuclear pathway to the hypoglossal nucleus of the opposite side exists in the reticular formation near nucleus ambiguous.


Sujet(s)
Infarctus cérébral/complications , Nerf hypoglosse , Moelle allongée/vascularisation , Palais mou , Paralysie/étiologie , Paralysie des cordes vocales/étiologie , Sujet âgé , Infarctus cérébral/anatomopathologie , Atteintes des nerfs crâniens/étiologie , Humains , Imagerie par résonance magnétique , Mâle , Syndrome
15.
Rinsho Shinkeigaku ; 35(9): 1040-3, 1995 Sep.
Article de Japonais | MEDLINE | ID: mdl-8565344

RÉSUMÉ

Here we report a 47-year-old man with dissecting aneurysm of the basilar artery who developed Foville's syndrome due to upper pons involvement. At first he had an abrupt onset of dysarthria and weakness in his left upper and lower extremities during his work. Neurological examination on admission revealed mild disturbance of consciousness, absent light reaction on the left side, hypesthesia of the left face, absent gag reflex, dysarthria, and left hemiparesis with ataxia. On the second hospital day he developed paralysis of conjugate eye movement to the right, left central facial palsy, and left hemiplegia, and hyperhidrosis of the left side of the body. He was diagnosed to have superior pons type of Foville's syndrome. Computed tomography showed low density area in the right upper pons, and the basilar artery had marked lateral shift, dilatation, and calcification. Vertebral angiography demonstrated dissecting aneurysm of the basilar artery. Although it is very rare that dissecting aneurysm of the basilar artery causes the brain stem symptoms, its possibility should be considered when computed tomography shows marked lateral shift, dilatation, and/or calcification of the basilar artery.


Sujet(s)
/complications , Artère basilaire , Paralysie faciale/étiologie , Hémiplégie/étiologie , Anévrysme intracrânien/complications , Ophtalmoplégie/étiologie , Pont , /imagerie diagnostique , Angiographie cérébrale , Humains , Anévrysme intracrânien/imagerie diagnostique , Mâle , Adulte d'âge moyen , Syndrome
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...